clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer…
News & Features
Biological Robots Show Healing Potential
News & Features
ACC and AHA Issue New Guideline for Preventing and Optimally Managing…
News & Features
Slow Brain Waves: A Natural Shield against Epileptic Activity
News & Features
Nasal Swab Test Separates High- from Low-Risk Lung Cancer Polyps
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Protein degradation
News & Features
BMS Pays $100M Upfront for Antibody Degrader Conjugate from Orum
Malorye Branca
-
November 8, 2023
0
News & Features
Schreiber’s Magnet Emerges from Stealth to Develop Alternative Molecular Glues
Malorye Branca
-
September 19, 2023
0
News & Features
Astellas and PeptiDream Ink $21M Plus Protein Degrader Deal
Malorye Branca
-
July 25, 2023
0
News & Features
Asked and Answered: Taking Protein Degradation to a New Therapeutic Frontier—Outside the Cell
Kathy Vuksanaj
-
February 10, 2023
0
News & Features
Blueprint Medicines, Proteovant Therapeutics Collaborate on Novel Targeted Protein Degrader Therapies
Chris Anderson
-
March 2, 2022
0
Related Content
Nutrient Found in Red Meat and Dairy Products Could Boost Cancer Therapies
Personalis Lands Tempus as Partner to Co-Commercialize Its MRD Test in Lung and Breast Cancer
AI Tool Could Spare Breast Cancer Patients Unnecessary Chemotherapy
Breast Cancer Cells Use Basement Membrane Barrier to Become Invasive
Inside Precision Medicine
